Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	MYT1	MYT1L MYT1 ST18	2.70e-08	3	57	3	PF08474
Domain	Myelin_TF	MYT1L MYT1 ST18	2.70e-08	3	57	3	IPR013681
Domain	IG	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1 MYBPC2	5.10e-07	421	57	10	SM00409
Domain	Ig_sub	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1 MYBPC2	5.10e-07	421	57	10	IPR003599
Domain	Znf_C2HC	MYT1L MYT1 ST18	5.36e-07	6	57	3	IPR002515
Domain	zf-C2HC	MYT1L MYT1 ST18	5.36e-07	6	57	3	PF01530
Domain	ZF_CCHHC	MYT1L MYT1 ST18	9.35e-07	7	57	3	PS51802
Domain	Ig_I-set	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 MYBPC2	1.74e-06	190	57	7	IPR013098
Domain	ig	HSPG2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1	1.74e-06	190	57	7	PF00047
Domain	Immunoglobulin	HSPG2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1	1.74e-06	190	57	7	IPR013151
Domain	I-set	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 MYBPC2	1.74e-06	190	57	7	PF07679
Domain	Ig-like_dom	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1 MYBPC2	2.55e-06	503	57	10	IPR007110
Domain	IG_LIKE	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 MYBPC2	1.63e-05	491	57	9	PS50835
Domain	Ig-like_fold	HSPG2 SEMA3C HMCN2 HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1 MYBPC2	4.83e-05	706	57	10	IPR013783
Domain	GFP	HMCN2 HMCN1	5.47e-05	4	57	2	IPR009017
Domain	G2F	HMCN2 HMCN1	5.47e-05	4	57	2	PF07474
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	5.47e-05	4	57	2	IPR006605
Domain	NIDOGEN_G2	HMCN2 HMCN1	5.47e-05	4	57	2	PS50993
Domain	IGc2	HSPG2 HMCN2 HMCN1 ICAM5 IGDCC3 MYBPC2	7.90e-05	235	57	6	SM00408
Domain	Ig_sub2	HSPG2 HMCN2 HMCN1 ICAM5 IGDCC3 MYBPC2	7.90e-05	235	57	6	IPR003598
Domain	Growth_fac_rcpt_	HSPG2 HMCN2 HMCN1 PCSK4 NOTCH4	1.12e-04	156	57	5	IPR009030
Domain	-	HSPG2 SEMA3C HMCN1 ICAM5 IGDCC3 KIR3DL1 KIR3DL2 KIR3DS1 MYBPC2	1.66e-04	663	57	9	2.60.40.10
Domain	EGF_CA	HSPG2 HMCN2 HMCN1 NOTCH4	5.24e-04	122	57	4	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 HMCN2 HMCN1 NOTCH4	5.57e-04	124	57	4	IPR001881
Domain	TIL	SSPOP MUC5AC	5.92e-04	12	57	2	PF01826
Domain	C8	SSPOP MUC5AC	5.92e-04	12	57	2	PF08742
Domain	Unchr_dom_Cys-rich	SSPOP MUC5AC	6.99e-04	13	57	2	IPR014853
Domain	C8	SSPOP MUC5AC	6.99e-04	13	57	2	SM00832
Domain	EGF_3	HSPG2 HMCN2 HMCN1 SSPOP NOTCH4	7.43e-04	235	57	5	PS50026
Domain	TIL_dom	SSPOP MUC5AC	8.13e-04	14	57	2	IPR002919
Domain	VWD	SSPOP MUC5AC	1.07e-03	16	57	2	SM00216
Domain	VWF_type-D	SSPOP MUC5AC	1.07e-03	16	57	2	IPR001846
Domain	VWFD	SSPOP MUC5AC	1.07e-03	16	57	2	PS51233
Domain	VWD	SSPOP MUC5AC	1.07e-03	16	57	2	PF00094
Domain	EGF_1	HSPG2 HMCN2 HMCN1 SSPOP NOTCH4	1.07e-03	255	57	5	PS00022
Domain	EGF_2	HSPG2 HMCN2 HMCN1 SSPOP NOTCH4	1.27e-03	265	57	5	PS01186
Domain	CTCK_1	SSPOP MUC5AC	1.36e-03	18	57	2	PS01185
Domain	-	HECTD1 PCSK4 SSPOP	1.44e-03	73	57	3	2.60.120.260
Domain	VWC_out	SSPOP MUC5AC	1.51e-03	19	57	2	SM00215
Domain	EGF_CA	HMCN2 HMCN1 NOTCH4	2.31e-03	86	57	3	PF07645
Domain	Cys_knot_C	SSPOP MUC5AC	2.62e-03	25	57	2	IPR006207
Domain	CTCK_2	SSPOP MUC5AC	2.62e-03	25	57	2	PS01225
Domain	Galactose-bd-like	HECTD1 PCSK4 SSPOP	2.97e-03	94	57	3	IPR008979
Domain	EGF_Ca-bd_CS	HMCN2 HMCN1 NOTCH4	3.24e-03	97	57	3	IPR018097
Domain	EGF_CA	HMCN2 HMCN1 NOTCH4	3.44e-03	99	57	3	PS01187
Domain	ASX_HYDROXYL	HMCN2 HMCN1 NOTCH4	3.53e-03	100	57	3	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	HMCN2 HMCN1 NOTCH4	4.16e-03	106	57	3	IPR000152
Domain	VWFC_1	SSPOP MUC5AC	5.39e-03	36	57	2	PS01208
Domain	VWC	SSPOP MUC5AC	6.00e-03	38	57	2	SM00214
Domain	VWFC_2	SSPOP MUC5AC	6.00e-03	38	57	2	PS50184
Domain	LDLR_class-A_CS	HSPG2 SSPOP	6.63e-03	40	57	2	IPR023415
Domain	EGF	HSPG2 HMCN1 NOTCH4	6.73e-03	126	57	3	PF00008
Domain	EGF-like_dom	HSPG2 HMCN2 HMCN1 NOTCH4	7.01e-03	249	57	4	IPR000742
Domain	VWF_dom	SSPOP MUC5AC	7.29e-03	42	57	2	IPR001007
Domain	EGF-like_CS	HSPG2 HMCN2 HMCN1 NOTCH4	8.24e-03	261	57	4	IPR013032
Domain	Ldl_recept_a	HSPG2 SSPOP	8.33e-03	45	57	2	PF00057
Domain	-	HSPG2 SSPOP	8.69e-03	46	57	2	4.10.400.10
Pubmed	Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.	KIR3DL1 KIR3DL2 KIR3DS1	5.13e-09	3	61	3	19019897
Pubmed	Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.	KIR3DL1 KIR3DL2 KIR3DS1	5.13e-09	3	61	3	11859120
Pubmed	Myt/NZF family transcription factors regulate neuronal differentiation of P19 cells.	MYT1L MYT1 ST18	2.05e-08	4	61	3	21540077
Pubmed	Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.	KIR3DL1 KIR3DL2 KIR3DS1	2.05e-08	4	61	3	27455421
Pubmed	Spatiotemporal expression pattern of Myt/NZF family zinc finger transcription factors during mouse nervous system development.	MYT1L MYT1 ST18	1.02e-07	6	61	3	24214099
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR3DL1 KIR3DL2 KIR3DS1	2.86e-07	8	61	3	9430221
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR3DL1 KIR3DL2 KIR3DS1	4.28e-07	9	61	3	8662091
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR3DL1 KIR3DL2 KIR3DS1	1.12e-06	12	61	3	20137308
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR3DL1 KIR3DL2 KIR3DS1	1.12e-06	12	61	3	17490516
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR3DL1 KIR3DL2 KIR3DS1	1.84e-06	14	61	3	19875891
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR3DL1 KIR3DL2 KIR3DS1	1.84e-06	14	61	3	15896204
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR3DL1 KIR3DL2 KIR3DS1	1.84e-06	14	61	3	19489269
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR3DL1 KIR3DL2 KIR3DS1	1.84e-06	14	61	3	18945962
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR3DL1 KIR3DL2 KIR3DS1	2.30e-06	15	61	3	20082646
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR3DL1 KIR3DL2 KIR3DS1	2.30e-06	15	61	3	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR3DL1 KIR3DL2 KIR3DS1	2.30e-06	15	61	3	19326408
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR3DL1 KIR3DL2 KIR3DS1	2.30e-06	15	61	3	19926642
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR3DL1 KIR3DL2 KIR3DS1	2.30e-06	15	61	3	20356536
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	19897003
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	18643961
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	19309280
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	19527230
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	20331834
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	20652381
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	18668235
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR3DL1 KIR3DL2 KIR3DS1	2.83e-06	16	61	3	20210919
Pubmed	A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	23524032
Pubmed	Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	35192601
Pubmed	Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	11098931
Pubmed	Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual.	KIR3DL1 KIR3DL2	3.03e-06	2	61	2	10774747
Pubmed	Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos.	CDC14C CDC14B	3.03e-06	2	61	2	19923902
Pubmed	Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	37647275
Pubmed	The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway.	CDC14C CDC14B	3.03e-06	2	61	2	21502810
Pubmed	Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	30365992
Pubmed	Association of the KIR3DS1013 and KIR3DL1004 alleles with susceptibility to ankylosing spondylitis.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	20131260
Pubmed	No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	19874556
Pubmed	Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	25112829
Pubmed	Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	17182560
Pubmed	Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors.	MYT1L MYT1	3.03e-06	2	61	2	29291346
Pubmed	Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	17694054
Pubmed	Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	27708262
Pubmed	Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	19008943
Pubmed	Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.	KIR3DL1 KIR3DL2	3.03e-06	2	61	2	11207248
Pubmed	Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.	HSPG2 MUC5AC	3.03e-06	2	61	2	23836919
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	3.03e-06	2	61	2	32035013
Pubmed	Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	19411600
Pubmed	Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein.	CDC14C CDC14B	3.03e-06	2	61	2	18547142
Pubmed	Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	18331531
Pubmed	Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	16805919
Pubmed	Contribution of functional KIR3DL1 to ankylosing spondylitis.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	20818412
Pubmed	HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	19386717
Pubmed	KIR3DL1 and KIR3DL2 gene copy number variation in axial spondyloarthritis.	KIR3DL1 KIR3DL2	3.03e-06	2	61	2	25940819
Pubmed	Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	19211742
Pubmed	Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	28942035
Pubmed	The profile of KIR3DL1 and KIR3DS1 alleles in an African American population resembles that found in African populations.	KIR3DL1 KIR3DS1	3.03e-06	2	61	2	20230527
Pubmed	Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.	KIR3DL1 KIR3DL2	3.03e-06	2	61	2	8777725
Pubmed	Gli regulates MUC5AC transcription in human gastrointestinal cells.	GLI1 MUC5AC	3.03e-06	2	61	2	25166306
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	19032228
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	20173792
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	19218127
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	20483367
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	20878400
Pubmed	Loss of Myt1 function partially compromises endocrine islet cell differentiation and pancreatic physiological function in the mouse.	MYT1L MYT1 ST18	3.43e-06	17	61	3	17928203
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	20650299
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR3DL1 KIR3DL2 KIR3DS1	3.43e-06	17	61	3	19761533
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR3DL1 KIR3DL2 KIR3DS1	4.11e-06	18	61	3	19046302
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR3DL1 KIR3DL2 KIR3DS1	4.11e-06	18	61	3	19846535
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR3DL1 KIR3DL2 KIR3DS1	4.11e-06	18	61	3	19630074
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR3DL1 KIR3DL2 KIR3DS1	4.11e-06	18	61	3	20519398
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR3DL1 KIR3DL2 KIR3DS1	4.11e-06	18	61	3	20580654
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR3DL1 KIR3DL2 KIR3DS1	4.11e-06	18	61	3	20210918
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR3DL1 KIR3DL2 KIR3DS1	4.88e-06	19	61	3	18778326
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR3DL1 KIR3DL2 KIR3DS1	4.88e-06	19	61	3	18571006
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR3DL1 KIR3DL2 KIR3DS1	4.88e-06	19	61	3	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR3DL1 KIR3DL2 KIR3DS1	4.88e-06	19	61	3	18848853
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR3DL1 KIR3DL2 KIR3DS1	5.73e-06	20	61	3	20426625
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR3DL1 KIR3DL2 KIR3DS1	5.73e-06	20	61	3	20193031
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR3DL1 KIR3DL2 KIR3DS1	6.68e-06	21	61	3	19861144
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR3DL1 KIR3DL2 KIR3DS1	7.72e-06	22	61	3	20492596
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	9.07e-06	3	61	2	12388743
Pubmed	The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.	KIR3DL1 KIR3DL2	9.07e-06	3	61	2	8760804
Pubmed	Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals.	KIR3DL1 KIR3DS1	9.07e-06	3	61	2	12826375
Pubmed	KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.	KIR3DL1 KIR3DS1	9.07e-06	3	61	2	19859704
Pubmed	Early-onset aging and defective DNA damage response in Cdc14b-deficient mice.	CDC14C CDC14B	9.07e-06	3	61	2	21262768
Pubmed	KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.	KIR3DL1 KIR3DS1	9.07e-06	3	61	2	24059286
Pubmed	Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.	KIR3DL2 KIR3DS1	9.07e-06	3	61	2	38262874
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	HMCN2 HMCN1	9.07e-06	3	61	2	17015624
Pubmed	DNA methylation maintains allele-specific KIR gene expression in human natural killer cells.	KIR3DL1 KIR3DL2	9.07e-06	3	61	2	12538663
Pubmed	Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription.	CDC14C CDC14B	9.07e-06	3	61	2	22355704
Pubmed	Synaptotagmin 4 Regulates Pancreatic β Cell Maturation by Modulating the Ca2+ Sensitivity of Insulin Secretion Vesicles.	MYT1L ST18	9.07e-06	3	61	2	29656931
Pubmed	Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.	KIR3DL1 KIR3DS1	9.07e-06	3	61	2	17301953
Pubmed	Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression.	MYT1L MYT1	9.07e-06	3	61	2	30312684
Pubmed	CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes.	CDC14C CDC14B	9.07e-06	3	61	2	19129509
Pubmed	GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.	GLI1 MUC5AC	9.07e-06	3	61	2	20972463
Interaction	KIR2DL2 interactions	KIR3DL1 KIR3DS1 FAAP100	7.02e-06	13	60	3	int:KIR2DL2
Cytoband	19q13.4	KIR3DL1 KIR3DL2 KIR3DS1	1.64e-04	79	61	3	19q13.4
GeneFamily	Zinc fingers C2H2C-type	MYT1L MYT1 ST18	9.28e-09	3	39	3	1261
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HSPG2 SEMA3C HMCN2 HMCN1 IGDCC3 MYBPC2	1.16e-06	161	39	6	593
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR3DL1 KIR3DL2 KIR3DS1	7.40e-06	18	39	3	620
GeneFamily	Fibulins	HMCN2 HMCN1	1.26e-04	8	39	2	556
GeneFamily	Immunoglobulin like domain containing	HSPG2 HMCN2 ICAM5	8.25e-03	193	39	3	594
GeneFamily	EF-hand domain containing	CACNA1B EFCAB6 FLG2	1.16e-02	219	39	3	863
GeneFamily	WD repeat domain containing	EML6 CSTF1 COP1	1.87e-02	262	39	3	362
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500	COX20 CACNA1B HMCN2 EFCAB6 PRICKLE3 MYT1 IGDCC3 KIR3DL2 ST18	6.51e-06	488	58	9	Facebase_RNAseq_e10.5_Medial Nasal Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	COX20 CACNA1B PTCHD1 HMCN2 EFCAB6 PRICKLE3 MYT1 EML6 IGDCC3 DNAAF9 KIR3DL2 ST18	1.08e-05	979	58	12	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYT1L DOCK3 PTCHD1 MYT1 EML6 ST18	7.58e-08	159	60	6	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 CACNA1B MYT1 ATP13A5 ST18	1.54e-06	145	60	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK3 CACNA1B MYT1 ATP13A5 ST18	2.65e-06	162	60	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L CACNA1B ICAM5 MYT1 ST18	4.93e-06	184	60	5	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L CACNA1B ICAM5 MYT1 ST18	4.93e-06	184	60	5	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYT1L CACNA1B MYT1 EML6 ST18	5.20e-06	186	60	5	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 PTCHD1 CCDC3 TACC2 HOXA1	5.20e-06	186	60	5	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 SEMA3C GLI1 CCDC3 TACC2	5.47e-06	188	60	5	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC\|mLN / shred on region, Cell_type, and subtype	SEMA3C EFCAB6 TTYH2 GLTPD2 ST18	7.04e-06	198	60	5	da84c76afe835aeee39da04b63c03549218b5d91
ToppCell	mLN-Dendritic_cell-Lymphoid_DC\|mLN / Region, Cell class and subclass	SEMA3C EFCAB6 TTYH2 GLTPD2 ST18	7.04e-06	198	60	5	3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 CCDC3 ZFTA NOTCH4	5.01e-05	150	60	4	322aa0c3fc159a4b2897daac881dfc744b24ffc4
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 SEMA3C ICAM5 SSPOP	5.54e-05	154	60	4	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B HSPG2 KCTD19 FLG2	5.69e-05	155	60	4	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B HMCN1 KCTD19 ATP13A5	6.43e-05	160	60	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B HMCN1 KCTD19 ATP13A5	6.43e-05	160	60	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NHSL1 EFCAB6 PRICKLE3 CCDC3	6.75e-05	162	60	4	2d28306c6125b31f11ea6d911a167b93a74907c5
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYT1L DOCK3 CACNA1B ST18	7.08e-05	164	60	4	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	15-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	DOCK3 SEMA3C CCDC3 TACC2	7.25e-05	165	60	4	531804467601e1ee1f771cffa21501f6d464ae10
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	7.25e-05	165	60	4	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	B_cells-pDCs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	HSPG2 SEMA3C KCTD19 NOTCH4	7.77e-05	168	60	4	dc8f94424f60ab56facdcffa969e7f3466ee1b6e
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|390C / Donor, Lineage, Cell class and subclass (all cells)	DOCK3 SEMA3C ST18 PPM1N	8.13e-05	170	60	4	3a7121d045f9ae54583b0f5f7436abf3665a1bce
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 SZT2 ZFTA NOTCH4	8.13e-05	170	60	4	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L HMCN2 MYT1 EML6	8.90e-05	174	60	4	742c73c9e090848b464323cb17579b86658c6792
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L HMCN2 MYT1 EML6	8.90e-05	174	60	4	7fed9722e64c60843092f2ba71256e3043011ef6
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 CCDC3 C8orf58 MYBPC2	8.90e-05	174	60	4	a0ccda8fd6f55251cdeff24cf66e72e4a31d2104
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	MYT1L DOCK3 CACNA1B ST18	9.10e-05	175	60	4	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	MYT1L DOCK3 CACNA1B ST18	9.10e-05	175	60	4	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB32 EFCAB6 KCTD19 EML6	9.51e-05	177	60	4	86c41d262142eeaa95ea7fa6668169eb1bb2953f
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 HMCN1 C8orf58 NOTCH4	9.72e-05	178	60	4	c30d3390fc4a7856f50ba8ff6694c0333165ddde
ToppCell	COPD-Epithelial-PNEC\|Epithelial / Disease state, Lineage and Cell class	MYT1L CACNA1B MYT1 ST18	9.93e-05	179	60	4	988d0853c391da1e5004f73f3678047418d3f6d3
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK3 SEMA3C CCDC3 TACC2	1.04e-04	181	60	4	25915e2500430a902db37d79a749ce2990b69810
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	MYT1L DOCK3 CACNA1B ST18	1.06e-04	182	60	4	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 HMCN1 ST18 SSPOP	1.10e-04	184	60	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 HMCN1 ST18 SSPOP	1.10e-04	184	60	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 HMCN1 ST18 SSPOP	1.10e-04	184	60	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK3 CACNA1B SEMA3C SLC44A5	1.13e-04	185	60	4	110d5f02759c8235b14aea524ea47199696094ea
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 PTCHD1 HMCN1 IGDCC3	1.15e-04	186	60	4	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK3 SEMA3C HMCN2 CCDC3	1.20e-04	188	60	4	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK3 SEMA3C CCDC3 TACC2	1.20e-04	188	60	4	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 SEMA3C GLI1 CCDC3	1.20e-04	188	60	4	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DOCK3 SEMA3C CCDC3 TACC2	1.20e-04	188	60	4	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	PTCHD1 HMCN2 SLC20A2 CCDC3	1.20e-04	188	60	4	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.22e-04	189	60	4	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 SEMA3C GLI1 CCDC3	1.22e-04	189	60	4	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK3 SEMA3C CCDC3 TACC2	1.25e-04	190	60	4	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	COPD-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	NHSL1 AGO2 TTYH2 ST18	1.27e-04	191	60	4	4e4887175200a57e1b041f2f131e3df774df3509
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 SEMA3C GLI1 CCDC3	1.27e-04	191	60	4	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.30e-04	192	60	4	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK3 SEMA3C CCDC3 TACC2	1.33e-04	193	60	4	000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.33e-04	193	60	4	cc355b2ed6510619cad969ae074126d7c8db784d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.38e-04	195	60	4	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.38e-04	195	60	4	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYT1L HMCN2 HMCN1 FLG2	1.38e-04	195	60	4	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYT1L HMCN2 HMCN1 FLG2	1.38e-04	195	60	4	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.41e-04	196	60	4	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN1 CCDC3 NOTCH4	1.41e-04	196	60	4	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN1 CCDC3 NOTCH4	1.44e-04	197	60	4	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HSPG2 CCDC3 NOTCH4 MYBPC2	1.44e-04	197	60	4	ad4a3b5da2190be9495382a2952991e1de9f190d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN1 CCDC3 NOTCH4	1.44e-04	197	60	4	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 SEMA3C HMCN2 HMCN1	1.46e-04	198	60	4	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	proximal-Epithelial-Neuroendocrine\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYT1L CACNA1B IGDCC3 ST18	1.46e-04	198	60	4	5dea6078488d584513c0bdbf5bba54877310b54a
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DOCK3 SEMA3C CCDC3 TACC2	1.46e-04	198	60	4	2d0c14f8cabab99bc6d7c27685437c78841c7245
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TTYH2 ST18 PPM1N ZNF646	1.46e-04	198	60	4	c64238379798ae6b292cc1914d60548c88e652de
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 HMCN1 TTYH2 NOTCH4	1.46e-04	198	60	4	72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1B SLC44A5 EML6	1.46e-04	198	60	4	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L CACNA1B SLC44A5 EML6	1.46e-04	198	60	4	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	proximal-Epithelial-Neuroendocrine-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYT1L CACNA1B IGDCC3 ST18	1.46e-04	198	60	4	00ccf3020667cf2130bc354b441b65c0b1b0e862
ToppCell	proximal-3-Epithelial-Neuroendocrine\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYT1L CACNA1B IGDCC3 ST18	1.46e-04	198	60	4	a6bc043faf68468d46bac441cf7447c236c7bae4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 HMCN1 TTYH2 NOTCH4	1.49e-04	199	60	4	9c40b3ee39860e9d8edafd007daec11abdd95435
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 HMCN1 CCDC3 NOTCH4	1.49e-04	199	60	4	1295f34a350bf48987e2fad411aaac3630efd3f1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 HMCN1 TTYH2 NOTCH4	1.49e-04	199	60	4	72b34bce8157abe389e95cd3ed8ba578dce0cbf6
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L NHSL1 SEMA3C SLC44A5	1.52e-04	200	60	4	19055194a5e0ea122f1b8fc62df44813f6843c95
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DOCK3 SEMA3C GLI1 TACC2	1.52e-04	200	60	4	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK3 SEMA3C GLI1 TACC2	1.52e-04	200	60	4	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DOCK3 SEMA3C GLI1 TACC2	1.52e-04	200	60	4	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Interneuron\|6m / Sample Type, Dataset, Time_group, and Cell type.	MYT1L MYT1 IGDCC3 ST18	1.52e-04	200	60	4	274871d632bbbe03720726a59ab3ec6d5fa0da11
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 HMCN2 CCDC3 NOTCH4	1.52e-04	200	60	4	93e13937ec74418a697c37d56f57509fb2154780
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	HSPG2 PTCHD1 HMCN1 IGDCC3	1.52e-04	200	60	4	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	MYT1L NHSL1 SEMA3C SLC44A5	1.52e-04	200	60	4	71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DOCK3 SEMA3C GLI1 TACC2	1.52e-04	200	60	4	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
Disease	episodic memory	SEMA3C EML6 FASTKD2	1.49e-04	52	58	3	EFO_0004333
Disease	systemic scleroderma	MYT1L FLG2 NOTCH4	6.35e-04	85	58	3	EFO_0000717
Disease	level of Sphingomyelin (d40:2) in blood serum	MYT1 GLTPD2	9.36e-04	23	58	2	OBA_2045181
Disease	Cytochrome-c Oxidase Deficiency	COX20 FASTKD2	1.02e-03	24	58	2	C0268237
Disease	malaria (is_implicated_in)	KIR3DL1 KIR3DS1	1.02e-03	24	58	2	DOID:12365 (is_implicated_in)
Disease	treatment-resistant hypertension	DOCK3 SEMA3C EML6	1.31e-03	109	58	3	EFO_1002006
Disease	hepatitis C (is_implicated_in)	KIR3DL1 KIR3DS1	1.39e-03	28	58	2	DOID:1883 (is_implicated_in)
Disease	tuberculosis (is_implicated_in)	KIR3DL1 KIR3DS1	1.39e-03	28	58	2	DOID:399 (is_implicated_in)
Disease	cytotoxicity measurement, response to clozapine	HMCN1 MYT1	1.49e-03	29	58	2	EFO_0006952, GO_0097338
Disease	Autistic Disorder	PTCHD1 MTF1 COP1 HOXA1	1.74e-03	261	58	4	C0004352
Disease	hypothyroidism	AGO2 KCTD19 MTF1 MYT1	2.37e-03	284	58	4	EFO_0004705
Disease	human immunodeficiency virus infectious disease (is_implicated_in)	KIR3DL1 KIR3DS1	2.69e-03	39	58	2	DOID:526 (is_implicated_in)
Disease	response to anticoagulant	SLC25A28 ZNF646	2.96e-03	41	58	2	GO_0061476
Disease	autistic disorder (is_implicated_in)	PTCHD1 HOXA1	3.11e-03	42	58	2	DOID:12849 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSRHSCAARPSAGVG	COP1	86	Q8NHY2
NSSTPRGEGGSCYHF	ATP13A5	781	Q4VNC0
AFCGPHSRARLESGY	CDC14B	226	O60729
STYRRIPDAAHGCSS	C8orf58	31	Q8NAV2
CTLGLSSGGRARHSY	CACNA1B	2316	Q00975
AFCGPHSRARLESGY	CDC14C	196	A4D256
CSHAGIQGTSRPSHY	AGO2	751	Q9UKV8
CRYDHTRPSAAAGGA	MKRN2	51	Q9H000
TRPSNHGTYRCVASN	HSPG2	3081	P98160
GTYRCRGSRPHSLTG	KIR3DL2	91	P43630
CRNAKRAGNPSTYSH	KCTD19	576	Q17RG1
RAGNPSTYSHCRGLC	KCTD19	581	Q17RG1
GDSGRRSHACGYSNS	FLG2	271	Q5D862
RHGGSLQAYCPELAA	KIAA0100	761	Q14667
HSGVYVCAANRPGTR	IGDCC3	301	Q8IVU1
RSECHLSAGPYRGTL	MCPH1	741	Q8NEM0
GVQCSDAYRAALGPH	GLTPD2	211	A6NH11
ALPIHAGRYTCSARN	HMCN2	3911	Q8NDA2
TTAHAGNYTCRGSHP	KIR3DL1	86	P43629
TPDHYSTLGRFNSCR	NHSL1	241	Q5SYE7
YTPSKENRHGTRCAG	PCSK4	191	Q6UW60
HAGTYRCEATNPRGS	ICAM5	546	Q9UMF0
SPRFLYLAHCGDSRA	PPM1N	171	Q8N819
QRRYNPSSHVLSGAC	SLC25A28	256	Q96A46
NSRCTSPGGSYGHLS	GLI1	111	P08151
LAEYSRQCTHAGGLP	MUC5AC	311	P98088
GTCSARAYPSDHRIT	HOXA1	21	P49639
YCLSLDHPGRSRSTS	FAAP100	86	Q0VG06
GRYTCLASSPAGHKS	HMCN1	2546	Q96RW7
PSRRRHYQCDAGSGS	PRICKLE3	526	O43900
QRSSSLHYAACFGRP	HECTD1	426	Q9ULT8
CISLGSGEPNRSSYH	DOCK3	461	Q8IZD9
NTPCARHSILYGSLG	COX20	26	Q5RI15
HSSPCRVYSRNGSPN	EFCAB6	26	Q5THR3
GSRLNLTGLGYFSCH	CCDC3	96	Q9BQI4
RDCSRIGIPYSSQGH	DNAAF9	156	Q5TEA3
RRAAYPTDSQGHFCG	SLC44A5	66	Q8NCS7
SLGHAARCAAYSPDG	EML6	1726	Q6ZMW3
SHKGPCRVATYSRDG	CSTF1	106	Q05048
TSAGSHPRAAYGRAL	SLC20A2	301	Q08357
ARGLHDSCPGQARYL	C18orf21	11	Q32NC0
HSGGYSQRLPNASAL	FPGT	126	O14772
LHTPGSNGRYSTIQC	SZT2	596	Q5T011
GHSCSRFYPTGKRRS	SEMA3C	536	Q99985
RSGRCQASGAPHYVT	SSPOP	1011	A2VEC9
RYASSLGAPLHNSCI	PTCHD1	691	Q96NR3
GCPRTYSTAGNLRTH	MTF1	146	Q14872
RSAYCLGSSHPRGFL	FASTKD2	641	Q9NYY8
TTAHAGNYTCRGSHP	KIR3DS1	86	Q14943
LAARGGGAYSHCRSL	NOTCH4	1886	Q99466
TGNYASHRSVSGCPL	ST18	736	O60284
GNYASHRSLSGCPRA	ST18	781	O60284
GAFAHCTREYSPNGR	C11orf42	91	Q8N5U0
LHDSYSRSGCRVPRG	RBMXL3	1036	Q8N7X1
PRGQLHSFCSYSSGL	TTYH2	446	Q9BSA4
PFRCTQCGRSYRHAG	ZNF646	1676	O15015
FLRACHLPRSNSGAA	TACC2	306	O95359
RTHGAAPYRCSLCGA	ZBTB32	421	Q9Y2Y4
SHGLRRHPSFSANCG	TASOR2	1941	Q5VWN6
RYCAGSCPRGARTQH	PSPN	91	O60542
RGPASSGRKYSDHCE	ZFTA	71	C9JLR9
AGYSAALNCAVRGHP	MYBPC2	1061	Q14324
ITGNYASHRSLSGCP	MYT1L	916	Q9UL68
TGKYASHRSASGCPL	MYT1L	966	Q9UL68
ITGNYASHRSLSGCP	MYT1	811	Q01538
TGNYASHRSLSGCPR	MYT1	856	Q01538
GKYASHRSASGCPLA	MYT1	906	Q01538